Sign in

CIK 0001706431 · Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
812730369
Phone
415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4/A Derivatives Options or other derivatives
  2. 4/A Derivatives Options or other derivatives
  3. 4/A Derivatives Options or other derivatives
  4. 4/A Derivatives Options or other derivatives
  5. 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $41.74 ($521,795)
  6. 4 Open-market sale Chief Business Officer sold 6,945 shares at $34.75 ($241,342)
  7. 4 Open-market sale EVP, Research & CSO sold 3,510 shares at $38.00 ($133,380)
  8. 4 Option exercise EVP, Research & CSO acquired 3,700 shares (option exercise)
  9. 4 Open-market sale EVP, Research & CSO sold 3,805 shares at $31.71 ($120,638)
  10. 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $31.90 ($398,694)
  11. 8-K Event Other events
  12. 4 Open-market sale EVP, Research & CSO sold 3,805 shares at an average $29.99 ($114,098)
  13. 4 Open-market sale EVP, Research & CSO sold 5,560 shares at $42.92 ($238,632)
  14. 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $32.89 ($411,159)
  15. 4 Open-market sale Chief Business Officer sold 6,943 shares at $39.15 ($271,796)
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 8-K Event Executive or director change
  19. 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $50.95 ($636,855)
  20. 4 Open-market sale EVP, Research & CSO sold 7,900 shares at $51.08 ($403,563)

Page 33 of 41 · 806 filings